TIME
A statement from the National Medical Products Administration said tests for HIV, hepatitis B and hepatitis C all turned out negative. The samples were from a …
China Investigates Reports of H.I.V.-Tainted Blood Plasma Treatment
By Amy Qin
BEIJING — Officials in Shanghai are investigating reports that a Chinese pharmaceutical company may have sold more than 12,000 units of a blood plasma product contaminated with H.I.V., potentially the latest in a series of scandals that have threatened to undermine public trust in China’s medical institutions and health care system.
In a statement on its website, the Shanghai Food and Drug Administration said Wednesday night that authorities had ordered the company, Shanghai Xinxing Medicine Company, to begin an emergency recall of the potentially tainted batch of intravenous immunoglobulin, a treatment made from pooled blood plasma that is often used to treat immune disorders, and halt its production.Read more: https://www.nytimes.com/2019/02/06/world/asia/china-blood-plasma-treatment.html
No comments:
Post a Comment